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The commensal microbiota co-exists in a mutualistic relationship with its human host. Commensal
microbes play critical roles in the regulation of host metabolism and immunity, while microbial col-
onization, conversely, is under control of host immunity and metabolic pathways. These interac-
tions are of central importance to the maintenance of homeostasis at mucosal surfaces and their
perturbation can provide the basis for atopic and chronic inﬂammatory diseases such as asthma
and inﬂammatory bowel disease (IBD). Recent evidence has revealed that natural killer T (NKT) cells,
a subgroup of T cells which recognizes self and microbial lipid antigens presented by CD1d, are key
mediators of host-microbial interactions. Mucosal and systemic NKT cell development is under con-
trol of the commensal microbiota, while CD1d regulates microbial colonization and inﬂuences the
composition of the intestinal microbiota. Here, we outline the mechanisms of bidirectional cross-
talk between the microbiota and CD1d-restricted NKT cells and discuss how a perturbation of these
processes can contribute to the pathogenesis of immune-mediated disorders at mucosal surfaces.
 2014 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
Recent sequencing-based approaches have revealed an unfore-
seen complexity of the commensal microbiota, which has co-
evolved with its human host, and provides the basis for numerous
mutualistic traits [1,2]. At birth, newborns leave an environment
considered sterile and are rapidly colonized by microbial organ-
isms derived from the maternal gestational tract as well as the skin
of caregivers [3–5]. While initial colonization is rapid, development
of an individual, adult-like microbial composition reﬂects a gradual
process, which requires several years for completion [3–6]. It is this
dynamic period of early postnatal microbial colonization that is
most susceptible to environmental and host genetic perturbations,
yet at the same time most critical for microbial-dependent devel-
opment of the host’s immune system [7]. Thus, the commensal
microbiota plays central roles in neonatal immune maturation
including the development of cryptopatches and isolated lymphoidfollicles, the maturation of Peyer’s patches, the formation of a
secretory IgA response, the regulation of intestinal mucus and anti-
microbial peptide secretion, and the control of mucosal and sys-
temic T cell differentiation [8]. Accordingly, mice raised in a
germ-free (GF) environment or treated at neonatal age with
broad-spectrum antibiotics exhibit a variety of alterations of the
innate and adaptive immune system, which may predispose to ato-
pic and chronic inﬂammatory disorders such as asthma and IBD
[9,8,7]. While the commensal microbiota is critical for the control
of host immunity and the prevention of immune-mediated disor-
ders, host-microbial interactions are bidirectional and the host’s
immune system is involved in shaping the composition of the com-
mensal microbiota [1]. In line with this concept, a number of pri-
mary immune defects have been described, which are associated
with alterations in the composition of the intestinal microbiota
and which contribute to microbial-dependent inﬂammatory as
well as metabolic diseases [10–14].
Interestingly, CD1d-restricted NKT cells have emerged as key
mediators of host-microbial interactions at mucosal surfaces.
Mucosal and systemic NKT cell development and maturation is
regulated by the commensal microbiota and the perturbation of
this process contributes to the pathogenesis of allergic and inﬂam-
matory disorders. Conversely, CD1d and NKT cells actively partici-
pate in the regulation of commensal microbial colonization. Here,
we provide a brief overview of the classiﬁcation and function of
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development at mucosal surfaces and in the systemic periphery,
outline the mechanisms of CD1d-dependent control of the intesti-
nal microbiota, and discuss the consequences of the perturbation
of these processes.
2. Natural killer T cells
NKT cells are a diverse group of T cells, which are deﬁned by
their ability to recognize self- and non-self-derived lipids in the
context of CD1d [15,16]. Various phenotypically and functionally
distinct subsets of NKT cells have been described and can be distin-
guished based, for example, on the lipids recognized by these cells,
their T cell receptor (TCR) repertoire, the expression of particular
cell surface markers, or the cytokines produced [16]. Most com-
monly, however, NKT cells are distinguished on the basis of their
TCR repertoire. Invariant (i) or type I NKT cells express an invariant
TCR-a chain, composed of Va14/Ja18 in mice and Va24/Ja18 in
humans, paired with a restricted set of TCR-b chains [15,16]. Type
I NKT cells can be speciﬁcally detected using CD1d tetramers
loaded with the marine sponge glycosphingolipid a-galactosylcer-
amide (aGalCer), which has contributed to the extensive charac-
terization of these cells. In addition, mice deﬁcient in iNKT cells
through genetic deletion of the Ja18 chain have allowed to delin-
eate the roles of iNKT cells in vivo, although recent work has
revealed that these mice harbor additional defects in the TCR rep-
ertoire, which may have affected results obtained with these mice
[17]. While iNKT cells are adaptive immune cells, which recognize
antigens in a TCR-dependent manner, they share various features
of innate immune cells. As such, their TCR recognizes diverse
CD1d-restricted lipids in a manner reminiscent of pattern recogni-
tion receptors (PRRs) [18,19]. Moreover, iNKT cells constitutively
transcribe cytokine mRNAs and secrete abundant amounts of cyto-
kines in an instant, innate-like manner upon activation [20]. Invari-
ant NKT cells are thus located at the interface of innate and
adaptive immunity, where they act as potent regulators of mucosal
and systemic immunity and control antimicrobial immune
responses, autoimmunity, and tumor development [16]. At muco-
sal surfaces, iNKT cells exert beneﬁcial effects through their
involvement in antimicrobial immunity, but can also actively con-
tribute to the pathogenesis of chronic immune-mediated disorders.
Accordingly, iNKT cells contribute to intestinal inﬂammation in
human IBD and are required for inﬂammation and inﬂammation-
associated tumorigenesis in mouse models of IBD and colitis-asso-
ciated cancer [21–26]. Moreover, iNKT cells contribute to pulmon-
ary inﬂammation and airway hyperreactivity (AHR) in human
asthma and mouse models of AHR [27–29]. iNKT cells thus play
central roles in mucosal immunity, which are associated with both
beneﬁcial and detrimental effects, and which are regulated by the
commensal microbiota as further outlined below.
In addition to iNKT cells, a subset of phenotypically and func-
tionally diverse CD1d-restricted T cells expressing non-Va14/
Va24 TCRs has been described and termed non-invariant or type
II NKT cells. A marker speciﬁc for type II NKT cells has not been
described. For this reason, our knowledge of these cells is based
on non-invariant NKT cell clones, the analysis of type II NKT cells
with known lipid reactivity using CD1d tetramers, and the indirect
characterization of type II NKT cells based on comparative studies
of Ja18-deﬁcient mice (lacking type I NKT cells) and CD1d-
deﬁcient mice (lacking both type I and II NKT cells). In accordance
with the diversity of the non-invariant NKT cell subset, these cells
play critical, but often tissue- and subset-speciﬁc roles in immune
regulation. As such, the sulfatide-reactive subset of type II NKT
cells has been demonstrated to suppress autoimmunity in mouse
models of multiple sclerosis and non-infectious hepatitis [30,31].In contrast, type II NKT cells contribute to hepatic inﬂammation
in viral hepatitis [32], while intestinal lysosulfatide-reactive type
II NKT cells are involved in inﬂammation and tissue damage in
human ulcerative colitis [22,25,26]. Non-invariant NKT cells thus
play diverse roles in immunity and can contribute to chronic
immune-mediated disorders such as IBD.
3. The commensal microbiota controls mucosal iNKT cell
development
Early studies in the pre-tetramer era suggested that NKT cells
exhibit unimpaired development in the absence of the intestinal
microbiota [33]. As such, the thymus, bone marrow, spleen, and
liver of GF mice harbored similar numbers of NKT cells, as deﬁned
by co-expression of the ab-TCR and the NK marker NK1.1, com-
pared to speciﬁc pathogen-free (SPF) mice. NKT cell expression of
activation, memory, and NK cell markers also did not differ
between GF and SPF mice and the proliferation of spleen cells in
response to the CD1d-restricted, iNKT cell-activating lipid a-Gal-
Cer was indistinguishable between SPF and GF mice [33]. Together,
these data suggested that the commensal microbiota is not
required for the development of NKT cells. More recent studies,
which applied a-GalCer/CD1d-loaded tetramers to unequivocally
identify iNKT cells, and which studied mucosal compartments in
addition to other primary and secondary lymphoid organs, con-
ﬁrmed the notion that iNKT cells, both in humans and mice, are
present in the absence of the commensal microbiota [34–38].
However, these studies also revealed a complex interplay of the
microbiota and iNKT cells, which is required for control of mucosal
iNKT cell homing and proliferation, for the maturation of iNKT cells
in the systemic periphery, and for prevention of iNKT cell-
associated inﬂammation at mucosal surfaces [34–38].
The analysis of iNKT cells at mucosal surfaces, and in particular
in the intestine, suggested that their abundance is indirectly
related to bacterial density with higher iNKT cell numbers
observed in the small intestine compared to the large intestine
and in the lamina propria compared to the intraepithelial compart-
ment [36]. Consistent with the concept of negative regulation of
intestinal iNKT cell numbers by the commensal microbiota,
increased relative and absolute numbers of iNKT cells were found
in the intestine but not the spleen, liver, and thymus of GF com-
pared to SPF mice [35,36]. Microbial regulation of intestinal iNKT
cell numbers was shown to occur early in postnatal development
with effects persisting for life, as evidenced by the restoration of
intestinal iNKT cell numbers upon microbial colonization of neona-
tal but not adult GF mice [35]. Interestingly, these principles were
not speciﬁc to the intestine but similarly observed in the lung,
where iNKT cell numbers were found to be increased in GF mice,
which could be restored by microbial colonization at neonatal
but not at adult age [35]. In addition, microbiota-dependent regu-
lation of mucosal iNKT cells differed from that observed for con-
ventional TCRab T cells, which were signiﬁcantly decreased in
numbers in intestinal compartments of GF mice and rats and
which expanded in response to microbial colonization [39–42].
Early and persistent effects of the commensal microbiota on
mucosal iNKT cells are dependent on CD1d and are achieved both
through the regulation of homing of iNKT cells to the mucosa as
well as the control of proliferation of resident iNKT cells within
the mucosal tissue. Olszak et al. reported that a CpG island 50 of
the Cxcl16 gene is hypermethylated in the colon and lungs of GF
mice, which is associated with increased epithelial expression of
CXCL16, and CXCL16-dependent mucosal homing of iNKT cells
(Fig. 1) [35]. Thus, microbiota-dependent epigenetic control of
the Cxcl16 locus regulates iNKT cell homing to the colon and lung.
An additional pathway of intestinal iNKT cell regulation was
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Fig. 1. Regulation of intestinal iNKT cells by the commensal microbiota. As shown
on the left, microbial-derived CD1d-restricted lipids such as Bf717 and a-GalCerBf
have been described, which are able to regulate the activation and proliferation of
iNKT cells [47,37]. Bf717 binds to CD1d but inhibits the proliferation of iNKT cells
thereby negatively regulating neonatal expansion of resident mucosal iNKT cells
[37]. a-GalCerBf, in contrast, activates iNKT cells and supports their proliferation,
although the consequences for intestinal iNKT cells are not known [47]. In addition,
as shown on the right, the commensal microbiota epigenetically regulates
transcription of the Cxcl16 locus. This leads to inhibition of CXCL16 expression
and reduced CXCL16-dependent recruitment of iNKT cells into the mucosa of the
intestine and lung during early postnatal development [35]. While this pathway is
also dependent on CD1d, it remains to be investigated whether microbiota-derived
CD1d lipids are involved in this process. IEC, intestinal epithelial cells; pAPC,
professional APC.
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monocolonization of GF mice with Bacteroides fragilis, which was
sufﬁcient to restore colonic iNKT cell levels, did not affect CXCL16
expression but suppressed colonic iNKT cell proliferation during a
narrow window of postnatal expansion of resident mucosal iNKT
cells. As such, these data demonstrate that the commensal micro-
biota regulates mucosal iNKT cell numbers through effects on iNKT
cell homing and the proliferation of resident iNKT cells.
While most studies that investigated microbial regulation of
mucosal NKT cell development focused on model organisms, ele-
gant studies by Loh and colleagues recently extended these ﬁnd-
ings to humans [38]. The authors investigated fetal human
tissues to study iNKT cell development during the prenatal period
and thus before microbial colonization of the host. Intriguingly,
similar to observations in GF mice [35,36], the human fetal small
intestine contained large numbers of iNKT cells, which were phe-
notypically and functionally mature as characterized by the
expression of activation, memory, and NK cell markers and the
secretion of TNF-a and IFN-c. Furthermore, in line with the obser-
vation of local mucosal iNKT cell proliferation in neonatal mice
[37], fetal human small intestinal iNKT cells readily proliferated
in response to CD1d-restricted antigens and/or cytokines. Thus,
similar to ﬁndings in mice, human intestinal iNKT cells can develop
and mature in the absence of the commensal microbiota and
strongly proliferate in response to lipid antigens. These observa-
tions are in contrast to conventional intestinal T cells, which are
present in intraepithelial and lamina propria compartments before
birth, but exhibit signiﬁcant expansion during postnatal develop-
ment, likely in response to microbial colonization [43].
One potential interpretation of the negative regulation of muco-
sal iNKT cells by the microbiota is that microbiota-independent
prenatal and neonatal mucosal iNKT cell development provides a
ﬁrst-line, innate-like defense at mucosal surfaces during the early
postnatal period. This iNKT cell-dependent defense may be critical
during neonatal life, when the unstable commensal microbiota
may not provide sufﬁcient ‘colonization resistance’ against inva-
sion by microbial pathogens and when the immature adaptive
immune system of the host may not be able to confer protectionagainst these pathogens. With the emergence of a stable commen-
sal microbiota and the maturation of host adaptive immunity, iNKT
cell-mediated antimicrobial immunity at mucosal surfaces may
become less critical and may in fact contribute to mucosal inﬂam-
mation, as further discussed below. As such, negative regulation of
mucosal iNKT cell development by the commensal microbiota may
represent an important developmental switch between a period of
neonatal iNKT cell-dependent antimicrobial immunity and the pre-
vention of iNKT cell-mediated pathology later in life.4. Commensal microbial mediators in the regulation of mucosal
iNKT cell development
Several questions arise from the observation of commensal
microbial regulation of mucosal iNKT cells. Are bacterial lipid anti-
gens, microbe-associated molecular patterns (MAMPs) or micro-
bial metabolites involved in this process? Are the observed
effects speciﬁc for bacteria or for particular bacterial phyla, fami-
lies or species? Are there distinct but functionally redundant path-
ways of commensal microbial regulation of mucosal iNKT cells?
Some of these questions have been addressed in recent studies,
the ﬁndings of which will be discussed in this section.
MAMPs can potently activate iNKT cells through indirect path-
ways involving toll-like receptor (TLR) signaling by dendritic cells
(DCs) and cytokine-dependent stimulation of iNKT cells by DC-
derived cytokines such as IL-12- and IL-18 [44–46]. While these
indirect pathways can lead to iNKT cell activation in the absence
of lipid antigen presentation [45], iNKT cells are most potently acti-
vated by a combination of cytokine signals and CD1d-restricted
lipid antigen presentation [44,46]. As such, these pathways have
been suggested to act as the predominant mode of iNKT cell activa-
tion in the context of microbial infection [44,46]. However,
although the commensal microbiota provides rich sources of
MAMPs, indirect TLR- and cytokine-dependent effects on iNKT cells
do not seem to be the primary mechanism responsible for com-
mensal-dependent regulation of mucosal iNKT cells. Thus, mice
deﬁcient in IL-12 or the TLR adaptor MyD88 do not exhibit altera-
tions in mucosal iNKT cell numbers or the iNKT cell phenotype
[35,36]. Moreover, recent studies have presented evidence for
direct, lipid antigen-dependent regulation of mucosal iNKT cells.
An et al. demonstrated that monocolonization of neonatal GF mice
with B. fragilis but a not with a mutant strain deﬁcient in serine
palmitoyltransferase, an enzyme required for sphingolipid biosyn-
thesis, restores mucosal iNKT cell levels [37]. Lipidomics and sub-
sequent functional studies revealed that B. fragilis contains an
abundant a-galactosylceramide (Bf717), which binds to CD1d but
fails to activate iNKT cells [37]. In this manner, Bf717 limits
CD1d-dependent colonic iNKT cell proliferation during early post-
natal development and contributes to mucosal homeostasis
(Fig. 1). The observation of increased CD1d-dependent expansion
of mucosal iNKT cells in the absence of commensal-derived inhib-
itory CD1d lipids such as Bf717 also indicates that host-derived
iNKT cell-activating CD1d lipids contribute to mucosal iNKT cell
proliferation during neonatal development. Although little is
known about potential self antigens involved in mucosal iNKT cell
regulation, it was recently reported that non-invariant intestinal
NKT cells exhibit broad reactivity to the host-derived sphingolipid
lysosulfatide, which suggests that similar self lipid antigens may
exist for iNKT cells [26].
Further complexity arises from the observation that microbial-
derived CD1d lipids differ in their ability to elicit iNKT cell activa-
tion and proliferation. Thus, Wieland Brown et al. reported an a-
GalCer derived from B. fragilis, which activated iNKT cells and pro-
moted their expansion, in contrast to Bf717 derived from the same
bacterial species (Fig. 1) [47]. Moreover, a CD1d-binding choleste-
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be associated with the expansion of a regulatory subset of iNKT
cells in the lung, which contributed to prevention of AHR in mice
[48]. Given the complexity of the commensal microbiota, future
studies are likely to reveal a large number of additional micro-
bial-derived CD1d lipids involved in the modulation of mucosal
iNKT cell development. In addition, further work is required to
delineate the structure–function relationships underlying the
observed divergent effects of microbial lipids on iNKT cells.
Finally, it is worthy to note that, in contrast to iNKT cells, little is
known about commensal microbial regulation of type II NKT cells.
However, recently described strategies to detect a least a subset of
type II NKT cells, based for example on CD1d tetramers [31,26] or
the detection of spontaneous IL-4 transcription by type II NKT cells
in mice lacking iNKT cells [32,49], will enable such analyses in the
near future and will provide insight into the microbial regulation of
non-invariant NKT cells at mucosal surfaces.
5. Microbial regulation of NKT cell-mediated mucosal
inﬂammation
The intestinal microbiota plays critical but often complex roles
in the pathogenesis of immune-mediated diseases such as IBD and
asthma. Infections can elicit ﬂares of these diseases in humans, and
disease models in mice are either dependent on the presence of the
intestinal microbiota (IBD) or actively elicited by microbial anti-
gens (asthma) [7]. However, antibiotic use in childhood is associ-
ated with an increased risk for development of IBD and asthma,
suggesting that interference with commensal microbial coloniza-
tion may promote disease susceptibility [7]. Given that iNKT cells
play central roles in inﬂammation and tissue damage in IBD and
asthma [25], the observation of microbial regulation of iNKT cells
raised the question of whether alterations in commensal microbial
colonization may promote iNKT cell-dependent inﬂammation at
mucosal surfaces. In line with this concept, it was recently reported
that GF mice, which harbor increased numbers of mucosal iNKT
cells [35,36], exhibit severe CD1d-dependent tissue damage and
inﬂammation in mouse models of asthma and IBD [35,37]. Suscep-
tibility to disease was prevented by commensal microbial coloni-
zation of GF mice at neonatal but not at adult age in accordance
with early and persistent effects of the microbiota on mucosal iNKT
cells [48,35,37]. Together, these data suggest that control of muco-
sal iNKT cell homing and proliferation by the commensal microbi-
ota is critical for prevention of iNKT cell-mediated pathology at
mucosal surfaces.
Remarkably, the observation of severe, CD1d-dependent
inﬂammation in GF mice also indicates that iNKT cell-mediated
inﬂammation does not require microbial antigens and may indeed
be elicited by self-derived lipids in accordance with a bona ﬁde
autoimmune disorder. This would further indicate that inhibition
of mucosal iNKT cell expansion by the commensal microbiota is
critical to prevent pathogenicity elicited by autoreactive iNKT cells,
which have escaped negative selection in the thymus. Consistent
with the concept of NKT cell-mediated autoreactivity and tissue
damage, recent work by the Strober group demonstrated that a
major fraction of lamina propria cells in human ulcerative colitis,
a subgroup of IBD, recognizes the self-derived glycosphingolipid
lysosulfatide in the context of CD1d, which is associated with IL-
13 production and cytotoxicity against the intestinal epithelium
[22,26]. Lysosulfatide reactivity was CD1d-restricted thus conﬁrm-
ing an NKT cell-dependent response. However, lysosulfatide-reac-
tive T cells could not be stained with a-GalCer-loaded CD1d
tetramers in line with the presence of non-invariant or type II
NKT cells [22,26]. In accordance with a pathogenic role of type II
NKT cells in intestinal inﬂammation, Liao and colleaguespreviously observed that transgenic expression of a non-invariant
NKT cell TCR is associated with spontaneous intestinal inﬂamma-
tion in mice, particularly in the presence of transgenic CD1d
expression [50]. Inﬂammation in this model, however, was depen-
dent on the intestinal microbiota as demonstrated by protective
effects of broad-spectrum antibiotics, which is in contrast to obser-
vations made for iNKT cells. These ﬁndings reveal the complexity
of commensal microbial NKT cell regulation at mucosal surfaces,
which is dependent on the respective subgroup of NKT cells, the
nature of microbial lipid antigens, and the timing of microbial
exposure. Furthermore, recent observations suggest that the type
of antigen presenting cell (APC) involved in CD1d-restricted anti-
gen presentation to NKT cells also inﬂuences the outcome of these
interactions. Thus, CD1d-restricted interactions of iNKT cells with
intestinal epithelial cells (IECs) promote IL-10 secretion and muco-
sal homeostasis, while CD1d-dependent interactions with bone
marrow-derived APCs contribute to intestinal inﬂammation [51].
Whether these divergent responses are the sole consequence of
differences in the expression of costimulatory molecules by IECs
and professional APCs or whether cell type-speciﬁc differences in
CD1d trafﬁcking and lipid acquisition contribute to this process
is currently unclear.
6. Commensal microbial control of iNKT cells at systemic sites
of immunity
Intriguing recent work has revealed that commensal microbial
regulation of iNKT cell development is not restricted tomucosal sur-
faces but also extends to systemic sites of immunity. Wingender
et al. noted that genetically identical inbredmice obtained from dif-
ferent commercial vendors exhibited differences in TCR Vb usage
and cytokine production by thymic, splenic, and hepatic iNKT cells
[36]. These differences in iNKT cell phenotype and function disap-
peared upon co-housing of newborn mice from different vendors
thus conﬁrming the involvement of a transmissible factor [36]. As
mice from these commercial vendors had been reported to harbor
a distinct intestinalmicrobiota [52], these results suggested apoten-
tialmicrobial origin of the observeddifferences in iNKT cells. Consis-
tently, GFmice as compared to SPFmice also exhibiteddifferences in
iNKT cells including an altered TCR Vb usage of thymic and splenic
iNKT cells, reduced expression of activation markers by thymic,
splenic, and hepatic iNKT cells, and impaired cytokine secretion by
splenic iNKT cells in response to CD1d-restricted antigen presenta-
tion (Fig. 2) [36]. Interestingly, similar ﬁndings were made for fetal
human iNKT cells, which develop in the absence of the commensal
microbiota. Thus,while fetal small intestinal iNKT cellswere pheno-
typically and functionally mature, their splenic counterparts exhib-
ited reduced expression of activation, memory, and NK cell markers
as well as increased expression of naïve T cell markers [38]. In con-
trast to iNKTcells, TCRVbusageof conventional T cells in the thymus
as well as cytokine secretion by splenic conventional T cells was
unimpaired in GF mice, again suggesting that microbial regulation
of iNKT cells differs from that observed for conventional T cells
[53]. Together, these fascinating observations demonstrate that
the commensal microbiota not only inﬂuences iNKT cell develop-
ment at mucosal surfaces but also elicits distant effects, which gov-
ern iNKTcell development andmaturation in the systemicperiphery
as well as in primary lymphoid organs.
The mechanisms underlying distal effects of the commensal
microbiota remain to be deﬁned but may include microbial metab-
olites, microbe-associated molecular patterns, bacterial-derived
CD1d lipids as well as changes in host-derived CD1d lipids as a
consequence of microbial colonization. While cytokine secretion
by professional APCs in response to PRR engagement can indirectly
activate iNKT cells as discussed above, unimpaired iNKT cell devel-
Fig. 2. The commensal microbiota shapes the systemic development of iNKT cells.
Compared to SPF mice, GF mice show an altered TCR Vb usage of thymic and splenic
iNKT cells, reduced expression of activation markers by thymic, splenic, and hepatic
iNKT cells, and impaired cytokine secretion by splenic iNKT cells [36]. Similarly,
human fetal splenic iNKT cells exhibit reduced expression of activation, memory,
and NK cell markers as well as increased expression of naïve T cell markers
compared to iNKT cells in peripheral blood of adults [38]. These observations
suggest that the commensal intestinal microbiota regulates the maturation of iNKT
cells in the systemic periphery. In addition, altered thymic TCR Vb usage suggests
that the maternal or neonatal commensal microbiota may inﬂuence thymic iNKT
cell selection and development. The mechanisms of systemic iNKT cell regulation
by the commensal microbiota are unknown. Colonization of GF mice with bacteria
containing CD1d lipids, but not with those devoid of CD1d lipid antigens, can
restore iNKT cell development, which indirectly suggests the involvement of
microbial-derived CD1d lipids in this process [36]. Alternatively, microbial metab-
olites or host-derived cytokines and chemokines secreted upon microbial recogni-
tion may contribute to systemic iNKT cell development.
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Trif argues against a TLR-dependent mechanism of such regulation
[36]. In addition, phenotypic restoration of iNKT cells upon mono-
colonization of GF mice with bacterial species containing CD1d-
restricted lipids (Sphingomonas yanoikuyae) but not with those pre-
sumably devoid of such lipids (Escherichia coli) indeed suggests
that microbial-derived CD1d lipids may shape iNKT cell develop-
ment at primary and secondary lymphoid organs [36]. However,
further work will be required to delineate the nature of these lip-
ids, the bacterial species they originate from, and the pathways
involved in the translocation of microbial CD1d lipids into the sys-
temic periphery. Furthermore, it will be important to study the
functional consequences of commensal microbial regulation of sys-
temic iNKT cell development and to investigate whether altera-
tions in this process may contribute to long-term consequences
of antibiotic treatment in infancy, such as an increased incidence
of NKT cell-dependent immune-mediated diseases [7].
7. CD1d in the regulation of commensal microbial colonization
As discussed above, the commensal microbiota controls the
development and function of NKT cells at mucosal and systemic
sites of immunity. Since host immunity shapes the composition
of the intestinal microbiota [1], these ﬁndings raise the question
of whether the CD1d-NKT axis may also exert control of the com-
mensal microbiota in the sense of a feedback mechanism involved
in host-microbial mutualism. Indeed, recent evidence suggests thatCD1d and NKT cells are not only critical for the control of microbial
pathogens but also regulate commensal microbial colonization
dynamics and the composition of the intestinal microbiota. Nie-
uwenhuis and colleagues observed that CD1d-deﬁcient mice exhi-
bit increased colonization of the lung upon exposure to
Pseudomonas aeruginosa, a Gram-negative bacterium associated
with clinically relevant infections of the airways and the urinary
tract [54]. Based on these observations, the authors investigated
whether similar mechanisms of CD1d-mediated control of bacte-
rial colonization also apply to the intestine and whether they
extend to members of the commensal microbiota. Reminiscent of
ﬁndings made in the lung, CD1d-deﬁcient compared to WT SPF
mice exhibited increased small but not large intestinal colonization
with P. aeruginosa. Studies in GF mice further revealed that CD1d is
required for the control of intestinal colonization by both Gram-
negative and Gram-positive members of the commensal intestinal
microbiota. As such, E. coli, Staphylococcus aureus, and Lactobacillus
gasseri exhibited a dramatically accelerated course of intestinal
colonization in GF CD1d-deﬁcient mice compared to WT litter-
mates [54]. Interestingly, bacteria seemed to persist at higher
numbers in the proximal small intestine but not the ileum, cecum
or colon of CD1d-KO mice, suggesting that colonization defects
may originate from the small intestine. Indeed, Paneth cells
(PCs), which are located at the bottom of small intestinal crypts
and which are involved in microbial control through the secretion
of antimicrobial peptides (AMPs), exhibited defects in the mor-
phology of AMP-containing granules as well as impaired AMP
release in response to bacterial colonization in CD1d-KO mice. In
addition, administration of the iNKT cell-activating lipid a-GalCer
was associated with degranulation of PCs in WT but not CD1d-
KO mice. Together, these results demonstrate that interactions
between CD1d and NKT cells are required for PC function and
PC-mediated control of microbial colonization.
PC-derived AMPs inﬂuence the composition of the intestinal
microbiota and limit the translocation of bacteria into mesenteric
lymph nodes (MLNs) [55,11]. Impaired AMP secretion in CD1d-
KO mice thus raised the question of whether these mice also exhi-
bit alterations in bacterial trafﬁcking and the composition of the
intestinal microbiota. Indeed, monocolonization of GF CD1d-KO
but not WT mice with E. coli was associated with bacterial translo-
cation into MLNs [54]. Moreover, CD1d-KO mice maintained under
SPF conditions harbored a distinct fecal microbiota compared to
WT littermates, which included a higher percentage of Bacteroide-
tes and a lower percentage of the Bacilli class of Firmicutes [54].
CD1d thus regulates the composition of the intestinal microbiota
and limits transepithelial bacterial translocation in the intestine.
The precise mechanisms through which CD1d-dependent inter-
actions between APCs and NKT cells regulate PC function remain to
be identiﬁed. NKT cells release abundant amounts of cytokines,
some of which inﬂuence the composition of the intestinal microbi-
ota. It is therefore possible that forward signaling by CD1d associ-
ated with NKT cell activation and cytokine production governs NKT
cell-mediated control of the microbiota. In addition, CD1d is
expressed by the intestinal epithelium including PCs [56,57] and
is subject to STAT3-dependent retrograde epithelial signaling upon
engagement of CD1d by NKT cells [51]. It is therefore tempting to
speculate whether reverse signaling by epithelial CD1d contributes
to PC function. Thus, further work is required to elucidate the
mechanisms of CD1d- and NKT cell-mediated control of intestinal
microbial colonization.8. Conclusion and perspective
Recent work has revealed a complex network of interactions
between the commensal microbiota and CD1d-restricted NKT cells,
S. Zeissig, R.S. Blumberg / FEBS Letters 588 (2014) 4188–4194 4193which together govern microbial colonization and control NKT
cell-dependent immunity and immunopathology. The relevance
of these interactions is highlighted by the observation that pertur-
bation of the cross-talk between NKT cells and the microbiota pro-
vides the basis for severe NKT cell-mediated inﬂammation at
mucosal surfaces. Despite these advances, further work is required
to delineate the spectrum of commensal-derived lipids involved in
CD1d-restricted regulation of iNKT cells and to deﬁne the struc-
tural elements, which dictate the functional consequences for iNKT
cell activation and function. In addition, the application of recently
developed tools for the identiﬁcation of type II NKT cells as well as
CD1a-, CD1b-, and CD1c-restricted T cells will be critical to inves-
tigate whether commensal microbial regulation is speciﬁc for iNKT
cells or similarly observed for non-invariant NKT cells and other
groups of lipid-reactive T cells.
Are cell type-dependent effects of CD1d-NKT cell interactions
[51] the consequence of differences in the CD1d-associated lipid
repertoire? Are temporal changes and regional differences in the
commensalmicrobiota associatedwithdistinct effects onNKT cells?
Are other exogenous factors such as nutrition-derived metabolites
involved in prenatal development of mucosal NKT cells, similar to
observations made for innate lymphoid cells [58]? And ﬁnally, is
CD1d-dependent regulation of PCs the consequence of retrograde
CD1d signaling or of forward signaling by NKT cell-derived cyto-
kines? These are critical questions, which remain to be addressed,
and which may ultimately provide novel opportunities for the pre-
vention and treatment of immune-mediated diseases through inter-
ference with commensal microbial NKT cell regulation.
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